Market Overview

Jim Cramer Advises His Viewers On Brink's, Medtronic And More

Related BCO
Earnings Scheduled For February 6, 2019
58 Biggest Movers From Yesterday
Related SGMO
The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs
72 Biggest Movers From Yesterday
Sangamo: A Competitive Intelligence Report On Empowers And Champions (Seeking Alpha)

On CNBC's "Mad Money Lightning Round", Jim Cramer said there was really no reason for a sell-off in Brink's Company (NYSE: BCO). He thinks the quarter was great and he wants to buy the stock.

Sangamo Therapeutics Inc (NASDAQ: SGMO) has disappointed before, but it's a great speculative stock, said Cramer.

Medtronic PLC (NYSE: MDT) is a total winner, believes Cramer.

Cramer would let Fiat Chrysler Automobiles NV (NYSE: FCAU) rally a bit and then he would sell the stock. He is not endorsing the company after the CEO passed away last summer.

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) could trade higher from its current price level, thinks Cramer.

Cramer likes EPR Properties (NYSE: EPR). He thinks it's really good.

Posted-In: CNBC Jim Cramer Mad Money mad money Lightning RoundMedia


Related Articles (BCO + EPR)

View Comments and Join the Discussion!

The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug

Christian Fromhertz's iShares MSCI Emerging Markets Index Trade